Recall Register

Drug recall: Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: Heritage Pharmaceuticals…

Class III FDA enforcement event 86659. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Failed impurities/ degradation specifications: Out of specification impurity results were observed during routine testing of stability samples for the impurity Felodipine Related compound A

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Heritage Pharmaceuticals Inc started this drug recall on 23 Oct 2020. The firm address in the FDA record is in East Brunswick, NJ. FDA put the recall in Class III. FDA event 86659 has 1 product record. The first FDA enforcement report date is 2 Dec 2020. The record gives the status Terminated, with the termination date 28 Jan 2022. 108 of the 342 drug events that started in 2020 have more product records. The median drug event of 2020 has 1 product record. The openFDA file has 342 drug events that started in 2020 and 362 that started in 2019.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

USA Nationwide

Recalling firm

Heritage Pharmaceuticals Inc, East Brunswick, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 86659: product records
Recall numberProductQuantityClassStatusReport date
D-0108-2021Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: Heritage Pharmaceuticals Inc. East Brunswick, NJ 08816 Made in India, NDC 23155-050-017176 bottlesClass IIITerminated2 Dec 2020

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2020
342
Share of these events in Class III
21%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
12

Other events of the firm

Other FDA enforcement events of Heritage Pharmaceuticals Inc
InitiatedProduct (first record)TypeClassRecords
30 Jul 2026CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet PharmaceutDrugClass II1
6 Oct 2025Desipramine Hydrochloride Tablets, USP, 10 mg, 100 - count bottle (NDC 23155-578-01), Rx only, Manufactured by: USV PrivDrugClass II6
23 Nov 2022Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. East BrunswickDrugClass II1
21 Apr 2021Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 0881DrugClass III1
21 May 2019PROCHLORPERAZINE EDISYLATE INJECTION, USP 10 mg/2mL (5mg/mL), 2mL Vial, Rx Only, Mfg by: Emcure Pharmaceuticals Ltd., HiDrugClass I2
3 May 2019Losartan Potassium Tablets, USP 50 mg 1000 film coated tablets Rx Only Manufactured by: Vivimed Life Sciences Private LiDrugClass II5
15 Feb 2019Etomidate Injection, USP 20 mg/10mL (2mg/mL) 10 mL Single-Dose Vial, Rx only, Manufactured for: Heritage PharmaceuticalsDrugClass II1
2 Jan 2019Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmaceuticals Ltd., HinjawDrugClass II1
15 Oct 2018Cidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only, Mfg. By Emcure Pharmaceutical Ltd HinjawadDrugClass II1
25 Mar 2015GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2.5 mg/500 mg, 100 ct Bottles, Rx Only. Manufactured for: Heritage PDrugClass II1

Heritage Pharmaceuticals Inc: all 12 events

Official channels

Cite this page

Recall Register. FDA enforcement event 86659. https://recallregister.com/fda/iii/86659/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: USA Nationwide
What quantity of product is in FDA event 86659?
The FDA record gives this quantity: 7176 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2020 have the same class?
21% of the 342 drug events that started in 2020 are in Class III.